PAK1 and cancer: However, this therapeutic approach must be carried out with knowledge of evidence that increased Pak1 activity plays a role in adverse aging mechanisms, neurodegenerative disorders, and oncogenesis and metastasis in various cancers (Sankaran et al. 2023).